ABT vs. JNJ
Compare and contrast key facts about Abbott Laboratories (ABT) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or JNJ.
Correlation
The correlation between ABT and JNJ is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABT vs. JNJ - Performance Comparison
Loading data...
Key characteristics
ABT:
1.49
JNJ:
0.06
ABT:
2.23
JNJ:
0.35
ABT:
1.28
JNJ:
1.05
ABT:
1.26
JNJ:
0.18
ABT:
7.58
JNJ:
0.49
ABT:
4.25%
JNJ:
6.54%
ABT:
21.04%
JNJ:
19.20%
ABT:
-45.66%
JNJ:
-52.60%
ABT:
-3.42%
JNJ:
-11.11%
Fundamentals
ABT:
$232.01B
JNJ:
$359.97B
ABT:
$7.99
JNJ:
$9.19
ABT:
16.69
JNJ:
16.28
ABT:
4.17
JNJ:
1.02
ABT:
5.48
JNJ:
4.03
ABT:
4.75
JNJ:
4.61
ABT:
$42.34B
JNJ:
$89.33B
ABT:
$23.67B
JNJ:
$61.01B
ABT:
$11.20B
JNJ:
$34.70B
Returns By Period
In the year-to-date period, ABT achieves a 20.36% return, which is significantly higher than JNJ's 5.48% return. Over the past 10 years, ABT has outperformed JNJ with an annualized return of 12.80%, while JNJ has yielded a comparatively lower 6.76% annualized return.
ABT
20.36%
3.93%
17.46%
31.12%
10.41%
12.80%
JNJ
5.48%
-1.68%
-0.15%
1.23%
2.97%
6.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. JNJ — Risk-Adjusted Performance Rank
ABT
JNJ
ABT vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
ABT vs. JNJ - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 1.69%, less than JNJ's 3.28% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 1.69% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
JNJ Johnson & Johnson | 3.28% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
ABT vs. JNJ - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for ABT and JNJ. For additional features, visit the drawdowns tool.
Loading data...
Volatility
ABT vs. JNJ - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 5.61%, while Johnson & Johnson (JNJ) has a volatility of 6.41%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
ABT vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. JNJ - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a gross profit of 14.54B and revenue of 21.89B. Therefore, the gross margin over that period was 66.4%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported an operating income of 6.30B and revenue of 21.89B, resulting in an operating margin of 28.8%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Johnson & Johnson reported a net income of 11.00B and revenue of 21.89B, resulting in a net margin of 50.2%.